Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda after SBRT in advanced NSCLC
NCT02492568Phase 2Completed
- Sponsor
- Netherlands Cancer Institute
- Start
- Jul 2015
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in non-small cell lung cancer (NSCLC), sponsored by Netherlands Cancer Institute. Started Jul 2015; status: completed.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02492568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492568.